'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

There are "no discussions" ongoing between AstraZeneca and ​Bristol Myers Squibb over a potential ‌deal, a senior source close to the matter told Reuters on Wednesday, quashing the ​prospect of a moot...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。